RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy
Source: Pixabay.com

RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy

  According to BioSpace, healthcare technology company RDMD has raised $14 million in Series A financing, and developed a partnership with UCB. In addition to growing their platform to discuss…

Continue Reading RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy
The First Ever “World Chagas Disease Day” Just Happened on April 14
Photo Credit:Content Providers(s): CDC/World Health Organization / Public domain

The First Ever “World Chagas Disease Day” Just Happened on April 14

  According to the UN News, the first ever World Chagas Disease Day was celebrated on April 14, 2020 to raise awareness for Chagas Disease, a rare disease spread by…

Continue Reading The First Ever “World Chagas Disease Day” Just Happened on April 14
Luspatercept Demonstrates Further Benefits in Transfusion-Dependent Beta Thalassemia
source: pixabay.com

Luspatercept Demonstrates Further Benefits in Transfusion-Dependent Beta Thalassemia

According to a story from Hematology Advisor, the drug luspatercept (marketed as Reblozyl) recently demonstrated its ability to reduce transfusion burden in patients with beta thalassemia that depend on regular…

Continue Reading Luspatercept Demonstrates Further Benefits in Transfusion-Dependent Beta Thalassemia
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Latest Published Research
source: pixabay.com

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Latest Published Research

The ME Association has recently published its latest weekly "research roundup" for the week of April 17th. This includes the latest research related to myalgic encephalomyelitis (ME), also known as…

Continue Reading Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Latest Published Research

Harvard Study Presents an Injectable Vaccine Causing Immunity Against Acute Myeloid Leukemia (AML) in Mice

According to a recent article in the Harvard Gazette, researchers from Harvard announced the results of a study involving animal models that brought about immunity and lasting recovery against acute…

Continue Reading Harvard Study Presents an Injectable Vaccine Causing Immunity Against Acute Myeloid Leukemia (AML) in Mice

The FDA Approves Tukysa™ for Metastatic HER2-Positive Breast Cancer

Seattle Genetics, Bothell, Washington recently issued an announcement through Drugs.com that the FDA approved Tukysa™ combined with capecitabine and trastuzumab for patients with metastatic HER2-positive breast cancer. The drug combination…

Continue Reading The FDA Approves Tukysa™ for Metastatic HER2-Positive Breast Cancer